Diabetes drug’s life-extending benefits

A common drug for diabetes may extend the lives of patients beyond those of apparently healthy people, researchers say today.

The research at Cardiff University, Wales, UK, may lead to new consideration of metformin as a possible life-extending drug – along with other widely-touted medicines such as statins.

Researchers say the unexpected potency of the drug may be linked to an ability to prevent cancer and heart disease.

The study involved more than 180,000 people and researchers say it showed that people with type 2 diabetes taking metformin enjoyed a "small but statistically significant" improvement in survival compared to people without the disease.

This did not apply to people with diabetes taking another drug, sulphonylureas.

The drug is designed to control glucose levels in the body.

The findings were reported today in Diabetes, Obesity and Metabolism.

Researcher Professor Craig Currie, from Cardiff University’s School of Medicine, said: "What we found was illuminating. Patients treated with metformin had a small but statistically significant improvement in survival compared with the cohort of non-diabetics, whereas those treated with sulphonylureas had a consistently reduced survival compared with non-diabetic patients.

"This was true even without any clever statistical manipulation."

He added: "Surprisingly, the findings indicate that this cheap and widely prescribed diabetic drug may have beneficial effects not only on patients with diabetes but also for people without, and interestingly, people with type 1 diabetes."

Diabetes, Obesity and Metabolism 8 August 2014; doi: 10.1111/dom.12354

, ,

Leave a Reply

Your email address will not be published. Required fields are marked *

Search

Categories

Monthly Posts

Our Clients

BSH
Practice Index